Anuras share price

Klicken Sie auf „ Alle akzeptieren“, verwenden wir und • personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen • die Effektivität von personalisierten Anzeigen und Inhalten zu messen, sowie • unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern Klicken Sie auf „ Alle ablehnen“, wenn Sie nicht möchten, dass wir und unsere Partner Cookies und personenbezogene Daten für diese zusätzlichen Zwecke verwenden. Wenn Sie Ihre Auswahl anpassen möchten, klicken Sie auf „ Datenschutzeinstellungen verwalten“. Sie können Ihre Einstellungen jederzeit ändern, indem Sie auf unseren Websites und Apps auf den Link „Datenschutz- und Cookie-Einstellungen“ oder „Datenschutz-Dashboard“ klicken. Weitere Informationen darüber, wie wir Ihre personenbezogenen Daten nutzen, finden Sie in unserer

• The company has shown a good profit growth of 44.2493254324728% for the Past 3 years. • The company has shown a good revenue growth of 28.5766183298604% for the Past 3 years. • Company has a healthy Interest coverage ratio of 8.14247250786648. • The Company has been maintaining an effective average operating margins of 23.2774708661717% in the last 5 years. • Company’s PEG ratio is 0.601526539310229. • Company has a healthy liquidity position with current ratio of 2.42892458996571. • The company has a high promoter holding of 60.81%. Quarterly Result (All Figures in Cr.) PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Net Sales 324.93 306.56 310.68 286.23 371.34 Total Expenditure 220.34 212.73 218.94 206.11 278.87 Operating Profit 104.59 93.83 91.74 80.12 92.48 Other Income -8.08 -9.41 -1.98 4.92 17.97 Interest 13.77 12.16 15.78 13.97 19.95 Depreciation 15.43 15.71 16.17 16.87 16.81 Exceptional Items 0 0 0 0 0 Profit Before Tax 67.32 56.55 57.81 54.2 73.68 Tax 22.23 19.15 16.61 15.55 22.4 Profit After Tax 45.09 37.4 41.2 38.65 51.28 Adjusted EPS (Rs) 4.5 3.73 4.11 3.61 4.77 Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.) PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Net Sales 342.77 501.5 528.88 810.89 1066 Total Expenditure 267.92 408.08 400.09 617.88 769.98 Operating Profit 74.85 93.42 128.79 193.01 296.02 Other Income 6.4 19.14 16.56 26.61 15.11 Interest 14.56 24.31 45.26 68.54 30.83 Depreciation 17.56 22.51 28.71 51.65 60.12 Exceptional I...

Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. It operates in life science related specialty chemicals and other specialty chemicals segments. The life science related specialty chemicals segment manufactures a variety of life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals. it manufactures agro intermediates and agro active ingredients for the agrochemicals industry which are used in the manufacturing of, amongst others, insecticides, fungicides and herbicides. The other specialty chemicals segment manufactures specialty chemicals which are used in diverse end-user segments, comprising specialty pigments, specialty dyes and polymer additives. The company was founded in 1984 and headquartered in Surat, India. Good chart structure Can buy above yesterday's high i.e. 1132 Targets 1145/1200 Stop loss 1100 I am just representing my views For educational purpose only. Good chart structure Can buy above yesterday's high i.e. 1132 Targets 1145/1200 Stop loss 1100 I am just representing my views For educational purpose only. #ANURAS trading above Resistance of 1107 Next Resistance is at 1454 Support is at 893 Volume is also on rise as the stock is moving up. Chart is self explanatory. Entry, Resistances and Support are mentioned on the chart. Disclaimer: This is for demonstration and educational purpose only. This #ANURAS trading above Resistance of 1107 Next Resistance is a...

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.